https://www.selleckchem.com/pr....oducts/levofloxacin-
Only 47 out of 84 patients (56%) measured the instructed amount of times on all 3 days. High satisfaction rates were reported in the patients receiving home monitoring. CONCLUSION Our first experience with home monitoring was disappointing since home monitoring of vital signs had poor compliance and not all patients were able to use the application. Further refinement of the home monitoring tool is needed to increase compliance and utility of the tool.BACKGROUND The prevalence of non-alcoholic steatohepatitis (NASH) in Jap
Like
Comment
Share
